Literature DB >> 11131654

Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase.

C Brekken1, Ø S Bruland, C de Lange Davies.   

Abstract

Elevated interstitial fluid pressure (IFP) in solid tumors may reduce the effect of systemically administered anticancer drugs. Modulation of the tumor extracellular matrix might reduce the elevated IFP. To study the influence of the microenvironment, the IFP was measured in human osteosarcoma xenografts grown both subcutaneously and orthotopically. The IFP response was recorded in xenografts grown at both sites after direct intratumoral injection of bovine testicular hyaluronidase (500 or 1600 units in 50 microliters saline). Control tumors received 50 microliters saline alone or 10% bovine serum albumin in saline. IFP was measured centrally in the tumors using the wick-in-needle technique, and mean arterial blood pressure was monitored after carotid cannulation. Tumor tissue sections were stained with hyaluronectin and analyzed for hyaluronan content using confocal laser scanning fluorescence microscopy. The baseline IFP was significantly higher in orthotopic (30 +/- 9 mmHg, n = 30) compared with subcutaneous tumors (17 +/- 6 mmHg, n = 11) of comparable sizes (p < 0.001). Injection of hyaluronidase reduced the IFP in both tumor models to 61-81% compared with controls 1 h after injection (p < 0.05), without affecting the mean arterial blood pressure significantly. The hyaluronan staining intensity increased in subcutaneous tumor sections, but remained unchanged in orthotopic tumor sections 1 h after injection of 1600 units of hyaluronidase. The IFP was restored within 48 h after hyaluronidase injection. Interestingly, IFP increased with tumor volume in orthotopic tumors, but not in subcutaneous tumors. In conclusion, intratumoral hyaluronidase injection reduces the IFP transiently in solid osteosarcoma xenografts. Furthermore, this study emphasizes that physiological parameters might differ significantly between human osteosarcoma xenografts grown subcutaneously versus orthotopically in nude mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131654

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.

Authors:  Alison Tedcastle; Sam Illingworth; Alice Brown; Leonard W Seymour; Kerry D Fisher
Journal:  Mol Ther       Date:  2015-12-28       Impact factor: 11.454

2.  Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth.

Authors:  Sonia Guedan; Juan José Rojas; Alena Gros; Elena Mercade; Manel Cascallo; Ramon Alemany
Journal:  Mol Ther       Date:  2010-05-04       Impact factor: 11.454

3.  Complexation of cell-penetrating peptide-polymer conjugates with polyanions controls cells uptake of HPMA copolymers and anti-tumor activity.

Authors:  Yosi Shamay; Lina Shpirt; Gonen Ashkenasy; Ayelet David
Journal:  Pharm Res       Date:  2013-09-10       Impact factor: 4.200

4.  Non-invasive imaging of barriers to drug delivery in tumors.

Authors:  Yaron Hassid; Erez Eyal; Raanan Margalit; Edna Furman-Haran; Hadassa Degani
Journal:  Microvasc Res       Date:  2008-06-27       Impact factor: 3.514

Review 5.  Pharmacologic and chemical adjuvants in tumor virotherapy.

Authors:  Christopher Alvarez-Breckenridge; Balveen Kaur; E Antonio Chiocca
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

6.  Extracellular matrix proteins and tumor angiogenesis.

Authors:  N E Campbell; L Kellenberger; J Greenaway; R A Moorehead; N M Linnerth-Petrik; J Petrik
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

7.  Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts.

Authors:  L Eikenes; M Tari; I Tufto; O S Bruland; C de Lange Davies
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

8.  Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents.

Authors:  C de Lange Davies; B Ø Engesaeter; I Haug; I W Ormberg; J Halgunset; C Brekken
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

9.  Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours.

Authors:  Sarah Jane Lunt; Tuula Mk Kalliomaki; Allison Brown; Victor X Yang; Michael Milosevic; Richard P Hill
Journal:  BMC Cancer       Date:  2008-01-07       Impact factor: 4.430

Review 10.  Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid.

Authors:  Gianfranco Baronzio; Gurdev Parmar; Miriam Baronzio
Journal:  Front Oncol       Date:  2015-07-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.